Work

A phase I study of the vitamin D3 analogue ILX23-7553 administered orally to patients with advanced solid tumors

Year: 2010

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/s10637-010-9492-5

Authors: Rajul K. Jain, Donald L. Trump, Merrill J. Egorin, Manuel Fernandez, Candace S. Johnson, Ramesh K. Ramanathan

Institutions: The University of Texas MD Anderson Cancer Center, Roswell Park Comprehensive Cancer Center, University of Pittsburgh, UPMC Hillman Cancer Center

Language: English

Topic: Vitamin D Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Cancer Institute, University of Pittsburgh, National Cancer Institute

Award: G3125387069

OpenAlex ID: W2006095870

FWCI: 0.386

Cites: 30

Cited by: 17

Related to: 10